Azithromycin for Acute Exacerbations of Asthma : The AZALEA Randomized Clinical Trial.
暂无分享,去创建一个
N. Thomson | P. Ind | S. Johnston | Dave Singh | C. Brightling | R. Chaudhuri | D. Ashby | P. Mallia | A. Chauhan | T. Harrison | Ernie H. C. Wong | B. Higgins | A. Mansur | M. Szigeti | M. Cross | Laura Robison | Z. Sattar | D. Jackson | C. Corrigan
[1] C. Pipper,et al. Azithromycin for episodes with asthma-like symptoms in young children aged 1–3 years: a randomised, double-blind, placebo-controlled trial , 2015, The Lancet Respiratory Medicine.
[2] M. Cabana,et al. Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial. , 2015, JAMA.
[3] J. Baty,et al. Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis. , 2015, The Journal of allergy and clinical immunology.
[4] British guideline on the management of asthma. , 2014, Thorax.
[5] A. Glanville. Community-acquired respiratory viruses after lung transplantation: common, sometimes silent, potentially lethal , 2013, Thorax.
[6] P. Barnes,et al. A Novel Macrolide Solithromycin Exerts Superior Anti-inflammatory Effect via NF-κB Inhibition , 2013, The Journal of Pharmacology and Experimental Therapeutics.
[7] Johny Verschakelen,et al. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial , 2013, Thorax.
[8] M. Raviglione,et al. The WHO policy package to combat antimicrobial resistance. , 2011, Bulletin of the World Health Organization.
[9] K. Bønnelykke,et al. Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study , 2010, BMJ : British Medical Journal.
[10] M. Leinonen,et al. Pneumococcal carriage is more common in asthmatic than in non‐asthmatic young men , 2010, The clinical respiratory journal.
[11] M. Leinonen,et al. Risk of invasive pneumococcal infections among working age adults with asthma , 2010, Thorax.
[12] W. Schaffner,et al. Risk Factors for Invasive Pneumococcal Disease in Children in the Era of Conjugate Vaccine Use , 2010, Pediatrics.
[13] S. Johnston,et al. Azithromycin induces anti-viral responses in bronchial epithelial cells , 2010, European Respiratory Journal.
[14] Lior Pachter,et al. Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.
[15] M. Zeitlinger,et al. Ketolides — The Modern Relatives of Macrolides , 2009, Clinical pharmacokinetics.
[16] S. Johnston,et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production , 2008, Proceedings of the National Academy of Sciences.
[17] S. Johnston,et al. Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages , 2008, Thorax.
[18] L. Drago,et al. In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations , 2008, BMC Microbiology.
[19] Stephen T Holgate,et al. Role of deficient type III interferon-λ production in asthma exacerbations , 2006, Nature Medicine.
[20] S. Johnston,et al. The effect of telithromycin in acute exacerbations of asthma. , 2006, The New England journal of medicine.
[21] R. Webby,et al. Respiratory Viruses Augment the Adhesion of Bacterial Pathogens to Respiratory Epithelium in a Viral Species- and Cell Type-Dependent Manner , 2006, Journal of Virology.
[22] S. Johnston,et al. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? , 2005, American journal of respiratory and critical care medicine.
[23] P. Gibson,et al. Interleukin-10 gene expression in acute virus-induced asthma. , 2005, American journal of respiratory and critical care medicine.
[24] W. Schaffner,et al. Asthma as a risk factor for invasive pneumococcal disease. , 2005, The New England journal of medicine.
[25] S. Johnston,et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus , 2005, The Journal of experimental medicine.
[26] M. Jacobs,et al. Activities of Two Novel Macrolides, GW 773546 and GW 708408, Compared with Those of Telithromycin, Erythromycin, Azithromycin, and Clarithromycin against Haemophilus influenzae , 2004, Antimicrobial Agents and Chemotherapy.
[27] S. Amyes,et al. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae. , 2004, The Journal of antimicrobial chemotherapy.
[28] S. Johnston,et al. Personal exposure to nitrogen dioxide (NO2) and the severity of virus-induced asthma in children , 2003, The Lancet.
[29] British guideline on the management of asthma. , 2003, Thorax.
[30] P. Gibson,et al. Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma , 2002, European Respiratory Journal.
[31] P. Gibson,et al. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma , 2002, European Respiratory Journal.
[32] G. Crompton,et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. , 2001, The European respiratory journal.
[33] S. Sullivan,et al. The health economics of asthma and rhinitis. I. Assessing the economic impact. , 2001, The Journal of allergy and clinical immunology.
[34] F. Blasi,et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. , 2000, European Respiratory Journal.
[35] S. Johnston,et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. , 1998, The European respiratory journal.
[36] M J Campbell,et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. , 1996, American journal of respiratory and critical care medicine.
[37] Stephen T Holgate,et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.